Ceftolozane-tazobactam versus levofloxacin in urinary tract infection

被引：5
|
作者：
Popa, Ciprian [1 ]
Mircheva, Miryana [1 ]
Kraemer, Bernhard K. [1 ]
Berghofen, Andrea [1 ]
Krueger, Bernd [1 ]
机构：
[1] Heidelberg Univ, Univ Med Mannheim, D-68167 Mannheim, BW, Germany
来源：
LANCET | 2015年 / 386卷 / 10000期
关键词：
D O I：
10.1016/S0140-6736(15)00262-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1241 / 1242
页数：2
相关论文
共 50 条
  • [21] Comparing ceftolozane/tazobactam versus piperacillin/tazobactam for the initial empiric therapy of urinary tract infections: A retrospective comparative study
    Nakagawa, Tomomi
    Shigehara, Kazuyoshi
    Shinzawa, Rei
    Yaegashi, Hiroshi
    Kawaguchi, Shohei
    Nohara, Takahiro
    Izumi, Kouji
    Mizokami, Atsushi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (01) : 12 - 16
  • [22] Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial
    Huntington, Jennifer A.
    Sakoulas, George
    Umeh, Obiamiwe
    Cloutier, Daniel J.
    Steenbergen, Judith N.
    Bliss, Caleb
    Goldstein, Ellie J. C.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (07) : 2014 - 2021
  • [23] The efficacy and safety of tazobactam/ceftolozane in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infection
    Arakawa, Soichi
    Kawahara, Kazuya
    Kawahara, Motoshi
    Yasuda, Mitsuru
    Fujimoto, Go
    Sato, Asako
    Yokokawa, Ruriko
    Yoshinari, Tomoko
    Rhee, Elizabeth G.
    Aoyama, Norihiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2019, 25 (02) : 104 - 110
  • [24] Impact of Renal Function on the Pharmacokinetics and Safety of Ceftolozane-Tazobactam
    Wooley, Myra
    Miller, Benjamin
    Krishna, Gopal
    Hershberger, Ellie
    Chandorkar, Gurudatt
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) : 2249 - 2255
  • [25] In Vitro Susceptibility of Ceftolozane-Tazobactam against Burkholderia pseudomallei
    Chan, Elaine
    Martelli, Paolo
    Hui, Suk-Wai
    Teng, Jade L. L.
    Lau, Susanna K. P.
    Woo, Patrick C. Y.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (05)
  • [26] First Study of Antimicrobial Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Pseudomonas aeruginosa Isolated from Patients with Urinary Tract Infection in Tehran, Iran
    Rahimzadeh, Mohammad
    Habibi, Mehri
    Bouzari, Saeid
    Karam, Mohammad Reza Asadi
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 533 - 541
  • [27] Modifiable Risk Factors for the Emergence of Ceftolozane-tazobactam Resistance
    Tamma, Pranita D.
    Beisken, Stephan
    Bergman, Yehudit
    Posch, Andreas E.
    Avdic, Edina
    Sharara, Sima L.
    Cosgrove, Sara E.
    Simner, Patricia J.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E4599 - E4606
  • [28] Ceftolozane-Tazobactam utilization in the national veterans affairs healthcare system
    Cusumano, Jaclyn A.
    Bodo, Emily
    Lopes, Vrishali
    McConeghy, Kevin W.
    Puzniak, Laura A.
    McCann, Eilish
    LaPlante, Kerry L.
    Caffrey, Aisling R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 508 - 509
  • [29] Evaluation of ceftolozane-tazobactam susceptibility on a French nationwide collection of Enterobacterales
    Jousset, Agnes B.
    Bernabeu, Sandrine
    Emeraud, Cecile
    Bonnin, Remy A.
    Lomont, Alexandra
    Zahar, Jean Ralph
    Merens, Audrey
    Isnard, Christophe
    Soismier, Nathalie
    Farfour, Eric
    Fihman, Vincent
    Yin, Nicolas
    Barraud, Olivier
    Jacquier, Herve
    Ranc, Anne-Gaelle
    Laurent, Frederic
    Corvec, Stephane
    d'Epenoux, Louise Ruffier
    Bille, Emmanuelle
    Degand, Nicolas
    Plouzeau, Chloe
    Guillard, Thomas
    Cattoir, Vincent
    Mizrahi, Asaf
    Grillon, Antoine
    Janvier, Frederic
    Le Brun, Cecile
    Amara, Marlene
    Bastide, Mathilda
    Lemonnier, Alban
    Dortet, Laurent
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2023, 32 : 78 - 84
  • [30] Population pharmacokinetics of tazobactam/ceftolozane in Japanese patients with complicated urinary tract infection and complicated intra-abdominal infection
    Kakara, Makoto
    Larson, Kajal
    Feng, Hwa-ping
    Shiomi, Mari
    Yoshitsugu, Hiroyuki
    Rizk, Matthew L.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2019, 25 (03) : 182 - 191
12345